Abstract
ABCL-504 Population Health and Economic Benefits of Pola-R-CHP versus R-CHOP in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) in the United States
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have